# Klineo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/klineo

- Industry: Healthcare
- Headquarters: Paris, France
- Website: www.klineo.fr/
- Total disclosed funding: $1.1M
- Latest round: Seed (Nov 7, 2023)
- Investors on record: 1

## About

Based in Paris, France, and founded in 2021 by Chief Executive Officer Thomas Peyresblanques and Chief Technology Officer Nicolas Drizard, Klineo operates as a healthcare company providing platform offers clinical trial access for breast, skin, and lymphoma patients. In April 2024, Klineo raised EUR 2 million in venture funding from Bpifrance, Pfizer Inc., and Wilco. 

Klineo providing a platform for patients that allows them to create an account and enter their medical history and requirements, allows them to search a for clinical trials. It suggests a suitable trails of interest and share them with their oncologist for discussion. In addition, the firm allows oncologists can review patient profiles, suggest relevant clinical trials, and connect patients with trial coordinators, also simplifying the referral process.

## Funding rounds

- Seed, Nov 7, 2023, $1.1M — Super Capital VC

## Investors

- Super Capital VC (https://capitalatlas.ai/funds/super-capital-vc) — Seed